By: Norton Healthcare July 27, 2026
By: Norton Healthcare
July 27, 2026
AGCT1531 A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors